Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-091733

President & CEO sold 5,466 shares at $17.92 ($97,974)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Warmuth Markus · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Sale : show line 1 in the form 10b5-1 −5,466 $17.92 $97,974 613,471 D
Open-market sales · 5,466 sh · avg $17.92 · $97,974
Loading xslF345X05/ownership.xml…